Dare Bioscience (DARE) Misses Q1 EPS by 50c

Dare Bioscience (NASDAQ: DARE) reported Q1 EPS of ($0.50). Revenue for the quarter came in at $25.42 million.

For earnings history and earnings-related data on Dare Bioscience (DARE) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Daré Bioscience Announces Pricing of $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules